Skip to main content

Table 2 Criteria for perioperative exclusion (n = 35)

From: Clinical course for patients with peritoneal carcinomatosis excluded from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

Criteria

CRC (n =19)

PMP (n =11)

MM (n =3)

GCC (n = 2)

Involvement of >5 regions

9 (31%)

NA

NA

1 (50%)

Involvement of pancreas

2 (7%)

1 (7%)

1 (14%)

0 (0%)

Involvement of portahepatis

1 (3%)

5 (33%)

2 (29%)

1 (50%)

Stenosis of the ureter(s)

2 (7%)

0 (0.0%)

0 (0%)

0 (0%)

≥2 bowel stenoses

3 (10%)

0 (0.0%)

0 (0%)

0 (0%)

Widespread carcinomatosis in bowel/mesentery

5 (17%)

8 (53%)

3 (43%)

0 (0%)

Retroperitoneal involvement

3 (10%)

0 (0%)

0 (0%)

0 (0%)

Othera

4 (14%)

1 (7%)

1 (14%)

0 (0%)

Total number of reasons

29 (100%)

15 (100%)

7 (100%)

2 (100%)

  1. aOther reasons included: liver metastases, para-aortal gland involvement, involvement of urinary bladder, severe adhesions and the stomach.
  2. CRC colorectal cancer, GCC goblet cell carcinoid, MM malignant peritoneal mesothelioma, PMP pseudomyxoma peritonei.